A review of the pharmacology and clinical efficacy of brivaracetam.

Clin Pharmacol · 2018 · PMC5783144 · PMID 29403319

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Percentage reduction over placebo in baseline-adjusted focal seizure frequency/week during the maintenance period (primary efficacy outcome) did not reach statistical significance for either dose of BRV, but significant differences were observed in several secondary efficacy outcomes.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.